Table 2. Domain-I mutations related to ion channel formation /conductance. |
S.no |
Toxin |
Residue(s) |
Mutation(s) |
Effect |
Reference |
1. |
Cry1Ab |
50 |
F-K |
Loss of toxicity due to impaired pore formation |
|
2. |
Cry1Ac |
'N' terminal fragment of toxin |
- |
Forms ion channel in PLB |
|
3. |
Cry3B2 |
Domain I alone |
- |
Forms ion channel on PLB but less than that of native toxin |
|
4. |
Cry1Ac |
92
|
A-D
|
Except Negatively charged substitutions all changes of Ala-92 were fully toxic |
|
Cry1Ac |
93 |
R-H R-G R-A R-S |
3-10 folds reduction in toxicity due to loss of positive charge. |
||
5. |
Cry1Ac |
206-215
|
R209A, P T213A W210L V218N Y211N, R, D |
No change in toxicity |
|
6. |
Cry1Ac |
a Helix-7
|
Substituted with Diphtheria Toxin Fragment |
Enhanced toxicity due to larger pore formation
|
|
7. |
Cry1Ac |
Helix 7 amino acids 210 211 211 214 |
W-C Y-D Y-C G-E |
No alteration in toxicity on tested insects
|
|
8. |
Cry1Aa |
- |
Disulphide bridging of Domain I region |
Reduced ion channel conductance in oxidized condition |
|
9. |
Cry1Aa |
521
|
R-K R-Q R-H R-E R-K |
Reverse the ion conductance Reverse the ion conductance No change in conductance No change in conductance No change in conductance |
|
10. |
Cry1Aa |
526 532
|
R-K R-K
|
Specifically reduces the toxin's inhibition of ISC |
|
11. |
Cry1Ac1 |
135 |
N-Q |
Binding to BBMV membrane not affected, pore formation affected |
|
12. |
Cry1Ac |
132 130 131 |
I-S, L, V, N M-T M-I |
Reduced the toxicity No change in toxicity No change in toxicity |
|